RobertMArisMD
Pulmonology • Chapel Hill, NCCritical Care Medicine
Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Aris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996- University of California (San Francisco)Residency, Occupational Medicine, 1988 - 1990
University of ColoradoResidency, Internal Medicine, 1986 - 1987- University of ColoradoInternship, Internal Medicine, 1984 - 1985
Vanderbilt University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1987 - Present
FL State Medical License 2018 - 2022
NC State Medical License 1993 - 2022
CO State Medical License 1986 - 1987- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis Start of enrollment: 1998 Oct 01
- Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 38 citationsC-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary MetastasisHendrik W. van Deventer, William T. O'Connor, W. June Brickey, Robert M. Aris, Jenny P.-Y. Ting
Cancer Research. 2005-04-15 - 62 citationsGrowth Factor Upregulation during Obliterative Bronchiolitis in the Mouse ModelRobert M. Aris, Sean P. Walsh, Worakij Chalermskulrat, Vasantha Hathwar, Isabel P. Neuringer
American Journal of Respiratory and Critical Care Medicine. 2002-08-01 - 52 citationsHuman leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.Worakij Chalermskulrat, Isabel P. Neuringer, John L. Schmitz, Diane J. Catellier, Matthew J. Gurka
Chest. 2003-06-01
Grant Support
- The Effects Of Alendronate On Bone Metabolism In Patients With CFNational Center For Research Resources2004
- Bisphosphonates On Bone Mineral Density In Patients With Cystic FibrosisNational Center For Research Resources2004
- Effects Of Alendronate On Bone Metabolism In Patients With Cystic FibrosisNational Center For Research Resources1998–2002
- Pamidronate On Bone Density In Patients With Cystic FibrosisNational Center For Research Resources1996–2002
- The Effects Of Alendronate On Bone Metabolism In Patients With Cystic FibrosisNational Center For Research Resources1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
